超薄液基细胞学和人乳头瘤病毒检测在宫颈癌和癌前病变筛查中的价值

来源 :中国肿瘤临床与康复 | 被引量 : 0次 | 上传用户:pyane
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨超薄液基细胞学(TCT)和高危人乳头瘤病毒DNA聚合酶链反应(HR-HPV DNA PCR)检测在宫颈癌及其癌前病变筛选中的价值。方法选取2008年2月至2013年2月查体女工中拟诊宫颈癌需要进行病理活检的480例患者进行TCT和HR-HPV DNA PCR检测,并与病理结果对照,比较TCT、HR-HPV DNA PCR及其联合检测的特异度、灵敏度、阳性预测值、阴性预测值和准确度。结果 TCT、HR-HPV DNA PCR及其联合检测的特异度分别为65.6%、58.8%和92.1%,灵敏度分别为75.4%、85.7%和69.5%,阳性预测值分别为56.6%、44.6%和65.8%,阴性预测值分别为86.8%、85.4%和88.9%,准确度分别为73.4%、60.4%和81.2%。HR-HPV DNA PCR的灵敏度显著高于TCT和联合检测(P<0.05),联合检测的特异度、准确度均显著高于TCT和HR-HPV DNA PCR(P<0.05),TCT和HR-HPV DNA PCR的阳性预测值显著低于联合检测(P<0.05),三者阴性预测值差异无统计学意义(P>0.05)。结论 TCT、HR-HPV DNA PCR均能有效筛选宫颈癌及其癌前病变,而联合检测则能使两种检查优势互补,提高诊断的准确度。 Objective To investigate the value of ultra-thin liquid-based cytology (TCT) and high-risk human papillomavirus DNA polymerase chain reaction (HR-HPV DNA PCR) in the screening of cervical cancer and precancerous lesions. Methods The TCT and HR-HPV DNA PCR were detected in 480 patients with pathological biopsy who were diagnosed with cervical cancer from February 2008 to February 2013. The TCT and HR-HPV DNA were compared with the pathological results PCR and its combined detection of specificity, sensitivity, positive predictive value, negative predictive value and accuracy. Results The specificities of TCT, HR-HPV DNA PCR and their combined detection were 65.6%, 58.8% and 92.1% respectively, with sensitivity of 75.4%, 85.7% and 69.5%, respectively, and the positive predictive values ​​were 56.6%, 44.6% and 65.8 % And negative predictive value were 86.8%, 85.4% and 88.9% respectively, with the accuracy of 73.4%, 60.4% and 81.2% respectively. The sensitivity of HR-HPV DNA PCR was significantly higher than that of TCT and combined detection (P <0.05). The specificity and accuracy of combined detection were significantly higher than that of TCT and HR-HPV DNA PCR (P <0.05) The positive predictive value of DNA PCR was significantly lower than that of the combined test (P <0.05), but there was no significant difference between the three predictive values ​​(P> 0.05). Conclusion Both TCT and HR-HPV DNA PCR can effectively screen cervical cancer and precancerous lesions, while combined detection can complement each other and improve the diagnostic accuracy.
其他文献
期刊
期刊
期刊
期刊
期刊
期刊
期刊
期刊
期刊
期刊